Drug intelligence / Profile preview

Resolv Endoscopic Hemostat System

Development stage: Preclinical
Lead developer: Hemostasis
Administration: Endoscopic Application

Overview

The Resolv Endoscopic Hemostat System is a novel powder-based, plant-based polysaccharide designed for endoscopic spray therapy to manage non-variceal upper gastrointestinal bleeding. It functions by achieving immediate hemostasis at the bleeding site. Clinical studies have demonstrated its safety and efficacy, showing a high success rate for immediate hemostasis and a low rebleeding rate in patients with non-variceal upper gastrointestinal bleeding.

Brand names: Resolv Endoscopic Hemostat System
Other names: Resolv

Beyond the preview

Go deeper on Resolv Endoscopic Hemostat System.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resolv Endoscopic Hemostat System.

Explore the full profile